PMID- 11526995 OWN - NLM STAT- MEDLINE DCOM- 20011210 LR - 20190815 IS - 0006-3223 (Print) IS - 0006-3223 (Linking) VI - 50 IP - 2 DP - 2001 Jul 15 TI - Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behavior in rats: differential effects of cocaine, d-amphetamine and 3,4- methylenedioxymethamphetamine ("Ecstasy"). PG - 137-43 AB - BACKGROUND: Psychomotor stimulant drugs can produce long-lasting changes in neurochemistry and behavior after multiple doses. In particular, neuroadaptations within corticolimbic brain structures that mediate incentive learning and motivated behavior have been demonstrated after chronic exposure to cocaine, d-amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA). As stimulus-reward learning is likely relevant to addictive behavior (i.e., augmented conditioned reward and stimulus control of behavior), we have investigated whether prior repeated administration of psychomotor stimulant drugs (of abuse, including cocaine, d-amphetamine, or MDMA, would affect the acquisition of Pavlovian approach behavior. METHODS: Water-deprived rats were tested for the acquisition of Pavlovian approach behavior after 5 days treatment with cocaine (15-20 mg/kg once or twice daily), d-amphetamine (2.5 mg/kg once or twice daily), or MDMA (2.5 mg/kg twice daily) followed by a 7-day, drug-free period. RESULTS: Prior repeated treatment with cocaine or d-amphetamine produced a significant enhancement of acquisition of Pavlovian approach behavior, indicating accelerated stimulus-reward learning, whereas MDMA administration produced increased inappropriate responding, indicating impulsivity. Abnormal drug-induced approach behavior was found to persist throughout the testing period. CONCLUSIONS: These studies demonstrate that psychomotor stimulant-induced sensitization can produce long-term alterations in stimulus-reward learning and impulse control that may contribute to the compulsive drug taking that typifies addiction. FAU - Taylor, J R AU - Taylor JR AD - Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06508-8068, USA. FAU - Jentsch, J D AU - Jentsch JD LA - eng GR - DA11026/DA/NIDA NIH HHS/United States GR - DA11717/DA/NIDA NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Biol Psychiatry JT - Biological psychiatry JID - 0213264 RN - 0 (Central Nervous System Stimulants) RN - I5Y540LHVR (Cocaine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - TZ47U051FI (Dextroamphetamine) SB - IM MH - Animals MH - Central Nervous System Stimulants/administration & dosage/*pharmacology MH - Cocaine/administration & dosage/*pharmacology MH - Conditioning, Classical/*drug effects MH - Dextroamphetamine/administration & dosage/*pharmacology MH - Impulsive Behavior/psychology MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage/*pharmacology MH - Psychomotor Performance/drug effects MH - Rats MH - Rats, Sprague-Dawley EDAT- 2001/08/31 10:00 MHDA- 2002/01/05 10:01 CRDT- 2001/08/31 10:00 PHST- 2001/08/31 10:00 [pubmed] PHST- 2002/01/05 10:01 [medline] PHST- 2001/08/31 10:00 [entrez] AID - S0006322301011064 [pii] AID - 10.1016/s0006-3223(01)01106-4 [doi] PST - ppublish SO - Biol Psychiatry. 2001 Jul 15;50(2):137-43. doi: 10.1016/s0006-3223(01)01106-4.